Stock APM APTORUM GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aptorum Group Limited

Equities

APM

KYG6096M1226

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
5.28 USD -3.65% Intraday chart for Aptorum Group Limited -8.17% +115.63%
Mar. 06 Top Midday Gainers MT
Mar. 06 YOOV Group Holding Limited entered into a entered into an Agreement and Plan of Merger to acquire Aptorum Group Limited for $250 million in a reverse merger transaction. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 439.8 460.2 84.01 53.44 19.64
Enterprise Value (EV) 1 437.1 460.4 54.82 45.29 24.51
P/E ratio -28.6 x -24.6 x 12.4 x -2.1 x -2 x
Yield - - - - -
Capitalization / Revenue 1,147,061,288 x 859,926,806 x 92,165,507 x 34,661,371 x 15,157,601 x
EV / Revenue 1,139,952,393 x 860,342,064 x 60,144,046 x 29,374,835 x 18,915,284 x
EV / EBITDA -45.2 x -27.2 x -2.97 x -2.51 x -1.5 x
EV / FCF -16.1 x 162 x -6.06 x -4.09 x -3.48 x
FCF Yield -6.19% 0.62% -16.5% -24.4% -28.7%
Price to Book 13.3 x 28.1 x 2.01 x 2.26 x 1.25 x
Nbr of stocks (in thousands) 2,898 2,904 3,401 3,563 3,571
Reference price 2 151.8 158.5 24.70 15.00 5.501
Announcement Date 4/15/19 4/29/20 4/19/21 4/29/22 4/28/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - 0.3834 0.5352 0.9115 1.542 1.296
EBITDA 1 -5.861 -9.665 -16.9 -18.43 -18.02 -16.3
EBIT 1 -5.92 -10.33 -18.2 -19.69 -19.21 -17.51
Operating Margin - -2,693.47% -3,400.52% -2,160.69% -1,245.77% -1,351.13%
Earnings before Tax (EBT) 1 -3.188 -15.13 -20.12 4.92 -27.11 -11.53
Net income 1 -3.174 -14.83 -18.69 7.067 -25.05 -9.8
Net margin - -3,867.97% -3,491.77% 775.29% -1,624.64% -756.2%
EPS 2 -0.9448 -5.314 -6.442 2.000 -7.150 -2.750
Free Cash Flow 1 -8.084 -27.08 2.835 -9.047 -11.07 -7.042
FCF margin - -7,061.55% 529.67% -992.53% -718.15% -543.44%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/5/18 4/15/19 4/29/20 4/19/21 4/29/22 4/28/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 0.22 - - 4.87
Net Cash position 1 17.7 2.73 - 29.2 8.15 -
Leverage (Debt/EBITDA) - - -0.0132 x - - -0.2987 x
Free Cash Flow 1 -8.08 -27.1 2.83 -9.05 -11.1 -7.04
ROE (net income / shareholders' equity) -11.5% -48.1% -84.5% 18.6% -97.4% -91%
ROA (Net income/ Total Assets) -13% -16.8% -33% -36.1% -36.3% -51.2%
Assets 1 24.42 88.04 56.7 -19.57 69 19.15
Book Value Per Share 2 10.90 11.40 5.630 12.30 6.620 4.400
Cash Flow per Share 2 5.830 4.140 1.790 1.030 2.280 0.5300
Capex 1 2.09 5.65 0.84 0.16 0.13 0.19
Capex / Sales - 1,472.55% 156.41% 17.7% 8.55% 14.42%
Announcement Date 9/5/18 4/15/19 4/29/20 4/19/21 4/29/22 4/28/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
APTORUM GROUP LIMITED Stock Aptorum Group Limited
+115.63% 28.89M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. APM Stock
  4. Financials Aptorum Group Limited